Early cellular signaling responses to axonal injury

Cell Communication and Signaling

Volumn 7, Issue , 2009, Pages

  Lukas, Thomas J ^a   Wang, Ai Ling ^a   Yuan, Ming ^a   Neufeld, Arthur H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951717070     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-7-5     Document Type: Article

References (51)

1. Early downregulation of IGF-I decides the fate of rat retinal ganglion cells after optic nerve injury. K Homma, Y Koriyama, K Mawatari, Y Higuchi, J Kosaka, S Kato, Neurochem Int 2007 50 741 748 10.1016/j.neuint.2007.01.011 17363111
2. Gene expression changes in the retina following optic nerve transection. N Piri, JM Kwong, M Song, D Elashoff, J Caprioli, Mol Vis 2006 12 1660 1673 17200666
3. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Z Yang, HA Quigley, ME Pease, Y Yang, J Qian, D Valenta, et al. Invest Ophthalmol Vis Sci 2007 48 5539 5548 10.1167/iovs.07-0542 18055803
4. A Critical role for Bim in retinal ganglion cell death. DP McKernan, TG Cotter, J Neurochem 2007 102 922 930 10.1111/j.1471-4159.2007.04573.x 17442051
5. Bax-dependent and independent pathways of retinal ganglion cell death induced by different damaging stimuli. Y Li, CL Schlamp, KP Poulsen, RW Nickells, Exp Eye Res 2000 71 209 213 10.1006/exer.2000.0873 10930325
6. Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. S Isenmann, C Wahl, S Krajewski, JC Reed, M Bahr, Eur J Neurosci 1997 9 1763 1772 10.1111/j.1460-9568.1997.tb01534.x 9283831
7. Age-related changes in neuronal susceptibility to damage: comparison of the retinal ganglion cells of young and old mice before and after optic nerve crush. AL Wang, M Yuan, AH Neufeld, Ann N Y Acad Sci 2007 1097 64 66 10.1196/annals.1379.027 17413012
8. Time course profiling of the retinal transcriptome after optic nerve transection and optic nerve crush. M Agudo, MC Perez-Marin, U Lonngren, P Sobrado, A Conesa, I Canovas, et al. Mol Vis 2008 14 1050 1063 18552980
9. GoMiner: a resource for biological interpretation of genomic and proteomic data. BR Zeeberg, W Feng, G Wang, MD Wang, AT Fojo, M Sunshine, et al. Genome Biol 2003 4 28 12702209 10.1186/gb-2003-4-4-r28
10. ProfCom: a web tool for profiling the complex functionality of gene groups identified from high-throughput data. AV Antonov, T Schmidt, Y Wang, HW Mewes, Nucleic Acids Res 2008 36 347 W351 18460543 10.1093/nar/gkn239
11. OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. PY Wang, J Weng, RG Anderson, Science 2005 307 1472 1476 10.1126/science.1107710 15746430
12. MAGI-3 regulates LPA-induced activation of Erk and RhoA. H Zhang, D Wang, H Sun, RA Hall, CC Yun, Cell Signal 2007 19 261 268 16904289 10.1016/j.cellsig.2006.06.008
13. UBPY-mediated epidermal growth factor receptor (EGFR) de-ubiquitination promotes EGFR degradation. HA Alwan, JE van Leeuwen, J Biol Chem 2007 282 1658 1669 10.1074/jbc.M604711200 17121848
14. Phosphorylation of glutamate receptors: a potential mechanism for the regulation of receptor function and psychostimulant action. JQ Wang, X Liu, G Zhang, NK Parelkar, A Arora, M Haines, et al. J Neurosci Res 2006 84 1621 1629 10.1002/jnr.21050 16983660
15. The nuclear factor SPBP contains different functional domains and stimulates the activity of various transcriptional activators. C Rekdal, E Sjottem, T Johansen, J Biol Chem 2000 275 40288 40300 10.1074/jbc.M006978200 10995766
16. The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation. S Bae, Y Bessho, M Hojo, R Kageyama, Development 2000 127 2933 2943 10851137
17. Inhibition of cortical astrocyte differentiation by Hes6 requires amino- and carboxy-terminal motifs important for dimerization and phosphorylation. S Belanger-Jasmin, E Llamosas, Y Tang, K Joachim, AM Osiceanu, S Jhas, et al. J Neurochem 2007 103 2022 2034 10.1111/j.1471-4159.2007.04902.x 17868320
18. Role of histone phosphorylation in chromatin dynamics and its implications in diseases. M Oki, H Aihara, T Ito, Subcell Biochem 2007 41 319 336 17484134
19. Role of histone modification in chromatin dynamics. T Ito, J Biochem 2007 141 5 609 614 10.1093/jb/mvm091 17405795
20. Hyperphosphorylation of histone H2A.X and dephosphorylation of histone H1 subtypes in the course of apoptosis. H Talasz, W Helliger, B Sarg, PL Debbage, B Puschendorf, H Lindner, Cell Death Differ 2002 9 27 39 10.1038/sj.cdd.4400925 11803372
21. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. C Lu, F Zhu, YY Cho, F Tang, T Zykova, WY Ma, et al. Mol Cell 2006 23 121 132 16818236 10.1016/j.molcel.2006.05.023
22. Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain. F Stadler, G Kolb, L Rubusch, SP Baker, EG Jones, S Akbarian, J Neurochem 2005 94 324 336 10.1111/j.1471-4159.2005.03190.x 15998284
23. The inhibitors of apoptosis: there is more to life than Bcl2. P Liston, WG Fong, RG Korneluk, Oncogene 2003 22 8568 8580 10.1038/sj.onc.1207101 14634619
24. Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. G Tezel, BC Chauhan, RP LeBlanc, MB Wax, Invest Ophthalmol Vis Sci 2003 44 3025 3033 12824248
25. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. H Zhang, R Zhang, Y Luo, A D'Alessio, JS Pober, W Min, J Biol Chem 2004 279 44955 44965 10.1074/jbc.M407617200 15310755
26. RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation. H Zhang, Y Lin, J Li, JS Pober, W Min, J Biol Chem 2007 282 14788 14796 10.1074/jbc.M701148200 17389591
27. Serologically defined colon cancer antigen 3 is necessary for the presentation of TNF receptor 1 on cell surface. N Neznanov, L Neznanova, B Angres, AV Gudkov, DNA Cell Biol 2005 24 777 785 10.1089/dna.2005.24.777 16332174
28. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. S Pype, W Declercq, A Ibrahimi, C Michiels, JG Van Rietschoten, N Dewulf, et al. J Biol Chem 2000 275 18586 18593 10.1074/jbc.M000531200 10764746
29. pVHL Acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. H Yang, YA Minamishima, Q Yan, S Schlisio, BL Ebert, X Zhang, et al. Mol Cell 2007 28 15 27 17936701 10.1016/j.molcel.2007.09. 010
30. FLASH coordinates NF-kappa B activity via TRAF2. YH Choi, KB Kim, HH Kim, GS Hong, YK Kwon, CW Chung, et al. J Biol Chem 2001 276 25073 25077 10.1074/jbc.M102941200 11340079
31. Interaction of TRAF6 with MAST205 regulates NF-kappaB activation and MAST205 stability. H Xiong, H Li, Y Chen, J Zhao, JC Unkeless, J Biol Chem 2004 279 43675 43683 10.1074/jbc.M404328200 15308666
32. A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. S Tagami, Y Eguchi, M Kinoshita, M Takeda, Y Tsujimoto, Oncogene 2000 19 5736 5746 10.1038/sj.onc.1203948 11126360
33. SOCS3 is required to temporally fine-tune photoreceptor cell differentiation. Y Ozawa, K Nakao, T Shimazaki, S Shimmura, T Kurihara, S Ishida, et al. Dev Biol 2007 303 591 600 10.1016/j.ydbio.2006.11.032 17198696
34. Differential role of Jak-STAT signaling in retinal degenerations. M Samardzija, A Wenzel, S Aufenberg, M Thiersch, C Reme, C Grimm, FASEB J 2006 20 2411 2413 10.1096/fj.06-5895fje 16966486
35. Rat retinal ganglion cells upregulate the pro-apoptotic BH3-only protein Bim after optic nerve transection. U Napankangas, N Lindqvist, D Lindholm, F Hallbook, Brain Res Mol Brain Res 2003 120 30 37 10.1016/j.molbrainres.2003.09. 016 14667574
36. Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. M Mandal, DJ Olson, T Sharma, RK Vadlamudi, R Kumar, Gastroenterology 2001 120 71 78 10.1053/gast.2001.20897 11208715
37. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. RT Libby, Y Li, OV Savinova, J Barter, RS Smith, RW Nickells, et al. PLoS Genet 2005 1 17 26 16103918 10.1371/journal.pgen.0010004
38. Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. R Ley, KE Ewings, K Hadfield, SJ Cook, Cell Death Differ 2005 12 1008 1014 10.1038/sj.cdd.4401688 15947788
39. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. R Ley, K Balmanno, K Hadfield, C Weston, SJ Cook, J Biol Chem 2003 278 18811 18816 10.1074/jbc.M301010200 12646560
40. Overexpression of SOCS-2 and SOCS-3 genes reverses erythroid overgrowth and IGF-I hypersensitivity of primary polycythemia vera (PV) cells. T Usenko, D Eskinazi, PN Correa, D Amato, Y Ben David, AA Axelrad, Leuk Lymphoma 2007 48 134 146 10.1080/10428190601043138 17325857
41. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. BR Dey, RW Furlanetto, P Nissley, Biochem Biophys Res Commun 2000 278 38 43 10.1006/bbrc.2000.3762 11071852
42. Molecular and cell-based approaches for neuroprotection in glaucoma. F Lebrun-Julien, A Di Polo, Optom Vis Sci 2008 85 417 424 10.1097/OPX. 0b013e31817841f7 18521011
43. The role of CaMKII in BDNF-mediated neuroprotection of retinal ganglion cells (RGC-5). W Fan, N Agarwal, NG Cooper, Brain Res 2006 1067 48 57 10.1016/j.brainres.2005.10.030 16337157
44. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. U Kilic, E Kilic, A Jarve, Z Guo, A Spudich, K Bieber, et al. J Neurosci 2006 26 12439 12446 10.1523/JNEUROSCI.0434-06.2006 17135405
45. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. H Levkovitch-Verbin, C Harris-Cerruti, Y Groner, LA Wheeler, M Schwartz, E Yoles, Invest Ophthalmol Vis Sci 2000 41 4169 4174 11095611
46. Optic nerve crush: protection and regeneration. M Schwartz, Brain Res Bull 2004 62 467 471 10.1016/S0361-9230(03)00076-5 15036559
47. Identification of the phosphotyrosine proteome from thrombin activated platelets. PB Maguire, KJ Wynne, DF Harney, NM O'Donoghue, G Stephens, DJ Fitzgerald, Proteomics 2002 2 642 648 10.1002/1615-9861(200206)2:6<642::AID- PROT642>3.0.CO;2-I 12112843
48. Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma cell line. PR Cutillas, B Geering, MD Waterfield, B Vanhaesebroeck, Mol Cell Proteomics 2005 4 1038 1051 10.1074/mcp.M500078-MCP200 15879432
49. Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis. TJ Lukas, W-W Luo, H Mao, N Cole, T Siddique, Mol Cell Proteomics 2006 5 1233 1244 10.1074/mcp.M500431-MCP200 16571896
50. PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. PV Hornbeck, I Chabra, JM Kornhauser, E Skrzypek, B Zhang, Proteomics 2004 4 1551 1561 10.1002/pmic.200300772 15174125
51. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. C Li, WH Wong, Proc Natl Acad Sci USA 2001 98 31 36 11134512 10.1073/pnas.011404098